Results from a groundbreaking clinical trial could soon change the way certain types of cancers are treated. A study published Sunday in the New England Journal of Medicine found that immunotherapy ...

A team led by Spaniard David Lagares is searching for a treatment for pulmonary fibrosis and other ailments associated with ...

For patients diagnosed with stage 4 cancer, a condition often accompanied by limited treatment options and grim prognoses, immunotherapy offers a new ray of hope. This groundbreaking approach utilizes ...

From cell-manufacturing laboratories to outpatient infusion facilities, health systems are rapidly adapting to a new kind of cancer treatment that demands individualized care, infrastructure and ...

Ultimately, Dr. Minn notes, success in immuno-oncology will be measured in multiple ways: Scientifically, by the depth of ...

A systematic review of 69 economic evaluations revealed that adjuvant immunotherapy was cost-effective in 58% of studies, with higher Quality-Adjusted Life-Year gains reported in 91% of cases.

VANCOUVER, BC, March 3, 2026 /PRNewswire/ --The global oncology market is projected to nearly triple from $279.98 billion in 2026 to an estimated $748.17 billion by 2035, as immunotherapy continues to ...

New research has shown that immunotherapy can be effective in treating prostate cancer in men who are selected based on the genetic characteristics of their tumors. In a recent study, it was found ...

Diamyd is an antigen-specific immunotherapy intended to preserve endogenous insulin production. The Food and Drug Administration (FDA) has granted Fast Track designation to Diamyd ® (recombinant human ...